NL192304C - Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. - Google Patents
Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. Download PDFInfo
- Publication number
- NL192304C NL192304C NL8700119A NL8700119A NL192304C NL 192304 C NL192304 C NL 192304C NL 8700119 A NL8700119 A NL 8700119A NL 8700119 A NL8700119 A NL 8700119A NL 192304 C NL192304 C NL 192304C
- Authority
- NL
- Netherlands
- Prior art keywords
- piperazine
- pyrrolidone
- elem
- found
- calculated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1135986 | 1986-01-21 | ||
| JP1136086 | 1986-01-21 | ||
| JP1136086 | 1986-01-21 | ||
| JP1135986 | 1986-01-21 | ||
| JP17516886 | 1986-07-24 | ||
| JP17516886 | 1986-07-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8700119A NL8700119A (nl) | 1987-08-17 |
| NL192304B NL192304B (nl) | 1997-01-06 |
| NL192304C true NL192304C (nl) | 1997-05-07 |
Family
ID=27279384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8700119A NL192304C (nl) | 1986-01-21 | 1987-01-20 | Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5102882A (es) |
| BE (1) | BE1003248A5 (es) |
| CA (1) | CA1323874C (es) |
| CH (1) | CH675418A5 (es) |
| DE (2) | DE3744947C2 (es) |
| ES (1) | ES2002083A6 (es) |
| FR (2) | FR2597100A1 (es) |
| GB (1) | GB2185483B (es) |
| IT (1) | IT1205715B (es) |
| NL (1) | NL192304C (es) |
| SE (1) | SE503436C2 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021439A (en) * | 1988-10-31 | 1991-06-04 | Takeda Chemical Industries, Ltd. | Cerebral function ameliorating agents related to Tan-950 A |
| IT1244507B (it) * | 1991-04-11 | 1994-07-15 | Sigma Tau Ind Farmaceuti | Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| FR2680508B1 (fr) * | 1991-08-20 | 1995-03-03 | Adir | Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| CA2168265C (en) * | 1993-07-28 | 1999-02-23 | Kiyoshi Kimura | Antidepressant |
| CA2157348A1 (en) * | 1994-09-01 | 1996-03-02 | Aventis Pharmaceuticals Inc. | 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds |
| GB9420784D0 (en) * | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| WO1997017973A1 (en) * | 1995-11-13 | 1997-05-22 | Smithkline Beecham Corporation | Hemoregulatory compounds |
| CN1210274C (zh) * | 2000-02-11 | 2005-07-13 | 沃泰克斯药物股份有限公司 | 哌嗪和哌啶衍生物 |
| CN100395236C (zh) * | 2002-10-03 | 2008-06-18 | 沃泰克斯药物股份有限公司 | 用于治疗神经病的哌嗪和哌啶衍生物 |
| CA2674291C (en) | 2007-01-12 | 2015-11-24 | Novartis Ag | New process |
| DE102008003826B4 (de) * | 2008-01-10 | 2010-07-22 | Clariant International Limited | Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze |
| DE102008003828B3 (de) | 2008-01-10 | 2009-09-03 | Clariant International Limited | Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze |
| JP5705984B2 (ja) | 2010-08-23 | 2015-04-22 | ノバルティス アーゲー | Ｎｅｐ阻害剤を製造するための中間体の調製方法 |
| EP3307913A4 (en) | 2015-06-15 | 2019-03-27 | The Children's Hospital of Philadelphia | METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM |
| JP7472024B2 (ja) | 2018-01-18 | 2024-04-22 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | ファソラセタムの固体形態 |
| BR112020014675A2 (pt) * | 2018-01-18 | 2021-02-17 | The Children's Hospital Of Philadelphia | formas cristalinas de fasoracetam |
| GB202300833D0 (en) * | 2023-01-19 | 2023-03-08 | Nrg Therapeutics Ltd | Novel compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3051722A (en) * | 1960-10-21 | 1962-08-28 | Lakeside Lab Inc | 5-pyrrolidone-2-carboxamides |
| JPS5015793B2 (es) * | 1972-06-07 | 1975-06-07 | ||
| JPS518266A (en) * | 1974-07-10 | 1976-01-23 | Sakai Chemical Industry Co | Piroridonjudotaino seizohoho |
| GB1492640A (en) * | 1975-07-08 | 1977-11-23 | Ucb Sa | L-pyroglutamyl-l-prolinamide |
| BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
| DE2924011C2 (de) * | 1979-06-13 | 1982-04-08 | A. Nattermann & Cie GmbH, 5000 Köln | Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten |
| HU180925B (en) * | 1979-06-28 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem |
| JPS56147766A (en) * | 1980-04-17 | 1981-11-16 | Sakai Chem Ind Co Ltd | Preparation of lactam |
| DE3031118A1 (de) * | 1980-08-18 | 1982-04-01 | Meditest Institut für medizinisch-pharmazeutische Untersuchungen GmbH & Co KG, 7958 Laupheim | N,n'-bis(5-oxo-1-methyl-pyrrolidin-2-yl-essigsaeure)-hydrazid, verfahren zu dessen herstellung und seine verwendung als arzneimittel |
| HU184481B (en) * | 1981-10-02 | 1984-08-28 | Richter Gedeon Vegyeszet | Process for producing tripeptides for diminishing appetite |
| GB2130590B (en) * | 1982-11-10 | 1986-01-08 | Erba Farmitalia | Peptides |
| US4483991A (en) * | 1983-01-17 | 1984-11-20 | American Home Products Corporation | Hypotensive agents |
| US4525476A (en) * | 1983-05-26 | 1985-06-25 | Warner-Lambert Company | N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators |
| IT1172391B (it) * | 1983-12-23 | 1987-06-18 | Polifarma Spa | Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche |
| DE3420193A1 (de) * | 1984-05-30 | 1985-12-05 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel |
-
1987
- 1987-01-16 FR FR8700485A patent/FR2597100A1/fr active Granted
- 1987-01-20 DE DE3744947A patent/DE3744947C2/de not_active Expired - Fee Related
- 1987-01-20 NL NL8700119A patent/NL192304C/nl not_active IP Right Cessation
- 1987-01-20 DE DE19873701494 patent/DE3701494A1/de active Granted
- 1987-01-20 ES ES8700128A patent/ES2002083A6/es not_active Expired
- 1987-01-20 CA CA000527706A patent/CA1323874C/en not_active Expired - Fee Related
- 1987-01-20 IT IT47545/87A patent/IT1205715B/it active
- 1987-01-20 SE SE8700203A patent/SE503436C2/xx not_active IP Right Cessation
- 1987-01-20 CH CH195/87A patent/CH675418A5/de not_active IP Right Cessation
- 1987-01-21 BE BE8700036A patent/BE1003248A5/fr not_active IP Right Cessation
- 1987-01-21 GB GB8701245A patent/GB2185483B/en not_active Expired - Fee Related
- 1987-09-28 FR FR8713376A patent/FR2613366A1/fr active Granted
-
1991
- 1991-02-26 US US07/661,523 patent/US5102882A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3744947C2 (es) | 1992-07-16 |
| IT1205715B (it) | 1989-03-31 |
| FR2613366B1 (es) | 1994-08-19 |
| GB2185483A (en) | 1987-07-22 |
| GB8701245D0 (en) | 1987-02-25 |
| CA1323874C (en) | 1993-11-02 |
| SE8700203D0 (sv) | 1987-01-20 |
| FR2597100A1 (fr) | 1987-10-16 |
| BE1003248A5 (fr) | 1992-02-11 |
| FR2613366A1 (fr) | 1988-10-07 |
| DE3701494A1 (de) | 1987-07-23 |
| NL192304B (nl) | 1997-01-06 |
| US5102882A (en) | 1992-04-07 |
| SE8700203L (sv) | 1987-07-22 |
| FR2597100B1 (es) | 1994-08-19 |
| NL8700119A (nl) | 1987-08-17 |
| CH675418A5 (es) | 1990-09-28 |
| IT8747545A0 (it) | 1987-01-20 |
| GB2185483B (en) | 1990-10-24 |
| SE503436C2 (sv) | 1996-06-17 |
| ES2002083A6 (es) | 1988-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL192304C (nl) | Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat. | |
| US3978045A (en) | N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof | |
| DK162389B (da) | Analogifremgangsmaade til fremstilling af 2-oe4-oe(4,4-dialkyl-2,6-piperidindion-1-yl)butylaa-1-piperazinylaapyrimidiner | |
| CA1242439A (en) | 1-¬(AMINOALKYL AND AMINOALKYLAMINO)CARBONYL AND THIOCARBONYL|-.alpha.,.alpha.-DIARYLPYRROLIDINE, PIPERIDINE AND HOMOPIPERIDINEACETAMIDES AND ACETONITRILES | |
| JP2927480B2 (ja) | ピペリジン系化合物、その製造方法及びこれを含有する医薬組成物 | |
| CZ292625B6 (cs) | Derivát triazolu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a použití | |
| SE503436C3 (sv) | Pyroglutamidderivat | |
| Boegesoe et al. | Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity | |
| NO313997B1 (no) | Nye N-substituerte sykliske aminer, fremgangsmåte ved fremstilling derav ogfarmasöytiske sammensetninger inneholdende slike | |
| HU208422B (en) | Process for producing 1-//diaryl-methoxy/-alkyl/-pyrrolidine- and 1-//diaryl-methoxy/-alkyl/-piperidine derivatives | |
| FI88300B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara diazinylpiperidinderivat av cykliska amider och imider | |
| US5449677A (en) | Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents | |
| AU600378B2 (en) | Piperidine derivatives, their preparation and their application in therapy | |
| US4826843A (en) | Cerebral function enhancing diazinylpiperidine derivatives | |
| SK143096A3 (en) | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same | |
| HU179361B (en) | Process for preparing indoly-methyl-piperidine derivatives | |
| JPH01193264A (ja) | 精神分裂病の治療に有効な１−（（５−（（４−置換−１−ピペラジニル）メチル）−ピロール−２−イル又はフラン−２−イル）メチル−２−ピペリジノン類 | |
| JP2513197B2 (ja) | ピログルタミド誘導体 | |
| US4670420A (en) | N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof | |
| HU194874B (en) | Process for the production of derivatives of 1-pirrolidin-2-ons of 1-/2-piramidinil/-piperazinil and medical compositions containg thereof | |
| FI107151B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2-[4-(4,4-bis(4-fluorifenyyli)butyyli)piperatsin-1-yyli]pyridin-3-yyli-karboksyyliestrereiden valmistamiseksi | |
| KR20080027925A (ko) | 신규한 1ｈ인돌피리딘카르복스아미드 유도체 및1ｈ인돌피페리딘카르복스아미드 및 이들의히드록실라아제 티로신 유도제로서의 용도 | |
| EP0646582A1 (en) | Useful hemi-hydrate form of a cerebral function enhancing agent | |
| AU4856293A (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents | |
| JPH01275557A (ja) | １―置換―４―ペンタフルオロフエノキシピペリジン類 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| V1 | Lapsed because of non-payment of the annual fee |
Effective date: 20000801 |